# ISR — current state

@goal: in-stent restenosis (스텐트 재협착) 차단 — DES 시대 잔여 5-10% 재협착 + neoatherosclerosis 표적의 비-mTOR 신규 후보 short-list로 차세대 코팅·약물코팅풍선(DCB) 후보 도출

## milestones

- [x] ISR 4-axis 기전 매핑 (neointimal hyperplasia · neoatherosclerosis · stent fracture · uncovered strut) → `ISR/M1_mechanism.md`
- [x] 현행 DES 약물 한계 — sirolimus · everolimus · zotarolimus · biolimus → `ISR/M2_current.md`
- [x] 비-mTOR 신규 표적 inventory — YAP/TAZ · HIF · ROCK · BET · Wnt → `ISR/M3_targets.md`
- [x] 후보 분자 short-list — drug-repurposing + 신규 → `ISR/M4_candidates.md`
- [x] 약물코팅풍선 (DCB) — paclitaxel vs sirolimus 비교 + carrier → `ISR/M5_dcb.md`
- [x] 차세대 BRS (bioresorbable scaffold) 재시도 — PLLA · Mg · Zn 합금 → `ISR/M6_brs.md`
- [x] M7 off-target / 안전성 — late stent thrombosis · delayed healing → `ISR/M7_safety.md`
- [x] 한국인 ISR registry 매핑 + 통합 ranking → `ISR/M8_rank.md`

## research (deep)

- [x] R1 arxiv/PubMed deep research sweep — 2023-2026 ISR/Mg-BRS/dual-DCB/ROCK coronary/NA OCT → `ISR/research/arxiv_deep_research.md`
- [x] R2 web/regulatory research — FDA letter · ESC 2024 · ACC/AHA 2024 · ClinicalTrials.gov pipeline → `ISR/research/regulatory_pipeline.md`
- [x] R3 external libraries inventory — stent/balloon suppliers · drug DBs · biomechanics · patent landscape → `ISR/research/external_libraries.md`

## verify (🔵 SUPPORTED-FORMAL push · per @D g5)

- [x] V1 ISR claim inventory + tier triage (🔵/🟢/🟡/🟠) → `ISR/verify/V1_claim_inventory.md`
- [x] V2 🔵 push — bio-physical closed-form identities → `hexa verify --expr` + atlas register → `ISR/verify/V2_formal_identities.md`
- [x] V3 🟢 push — DFT/MD/CFD/FEA numerical recompute (drug release · Mg corrosion · stent biomech) → `ISR/verify/V3_numerical_recompute.md`
- [ ] V4 final tier ledger — 🔵 + 🟢 + 🟡 verbatim verdict 통합 + 🟠 honest deferred → `ISR/verify/V4_tier_ledger.md`
